Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, signaling strong market confidence and positive business fundamentals [1] Group 1: Share Repurchase Activity - On February 5, Yidu Tech announced a share repurchase, buying approximately 1.88 million shares at around HKD 5.55 per share, totaling over HKD 10 million [1] - This marks the ninth consecutive trading day of intensive repurchases, with a cumulative expenditure of approximately HKD 44 million [1] - The daily repurchase amount continues to maintain a high level, indicating strong commitment from the company [1] Group 2: Southbound Capital Inflow - Southbound capital has shown consistent interest in Yidu Tech, with net purchases for nine consecutive days, totaling HKD 44.97 million as of February 2 [1] - As of February 2, southbound investors held approximately 237 million shares, representing 22.14% of the company's total shares, with a market value of about HKD 1.333 billion [1] - The combination of the company's share repurchase and the inflow of southbound capital sends a positive signal to the market [1] Group 3: Business Fundamentals - The positive movement in capital aligns with the company's recent business developments, including partnerships for "AI + health management" in Shenzhen and the launch of a general medicine AI assistant with Chongqing Medical University [1] - The ongoing share repurchases and capital inflows reflect market recognition of the company's business value and strategic execution capabilities [1]

Group 1 - The core viewpoint of the article is that Yidu Technology has been actively repurchasing its shares, signaling confidence in its business value and strategic execution [2] - On February 5, Yidu Technology announced a share buyback of approximately 1.88 million shares at a price of about 5.55 HKD per share, totaling over 10 million HKD [2] - This marks the company's ninth consecutive trading day of share repurchases, with a cumulative expenditure of around 44 million HKD [2] Group 2 - According to Wind data as of February 2, southbound funds have net bought Yidu Technology shares for nine consecutive trading days [2] - The company's ongoing buybacks, along with the continuous inflow of southbound funds, convey a positive signal to the market [2] - Yidu Technology has recently partnered with Shenzhen Nanshan Hospital for an "AI + Health Management" initiative and launched a general medicine diagnostic AI assistant in collaboration with Chongqing Medical University First Affiliated Hospital [2]

Core Viewpoint - The company, Yidu Tech (02158), has been actively repurchasing its shares, signaling strong market confidence and positive business fundamentals [1] Group 1: Share Repurchase Activity - On February 5, Yidu Tech announced a share repurchase, buying approximately 1.88 million shares at around HKD 5.55 per share, totaling over HKD 10 million [1] - This marks the ninth consecutive trading day of intensive repurchases, with a cumulative expenditure of approximately HKD 44 million [1] - The daily repurchase amount continues to maintain a high level, reflecting the company's commitment to enhancing shareholder value [1] Group 2: Capital Inflows - Southbound funds have shown consistent interest in Yidu Tech, with net purchases for nine consecutive days, totaling HKD 44.97 million as of February 2 [1] - As of February 2, southbound funds held approximately 237 million shares of the company, representing 22.14% of total shares, with a market value of about HKD 1.333 billion [1] - The combination of the company's share repurchase and the inflow of southbound funds sends a positive signal to the market [1] Group 3: Business Fundamentals - The positive capital movements align with the company's recent business developments, including partnerships for "AI + health management" with Shenzhen Nanshan Hospital and the launch of a general medicine AI assistant with Chongqing Medical University First Affiliated Hospital [1] - The ongoing share repurchase and capital inflow reflect market recognition of the company's business value and strategic execution capabilities [1]

Group 1 - The core point of the news is that Yidu Tech (02158) has been actively repurchasing its shares, with a recent buyback of over 880,000 shares at approximately HKD 5.65 per share, totaling around HKD 5 million, marking a new high for single-day repurchase amounts [1] - The company has conducted share buybacks for six consecutive trading days, with a cumulative repurchase amount nearing HKD 15 million, indicating a strong commitment to its buyback plan and confidence in its intrinsic value and long-term growth prospects [1] - The ongoing buyback activity is supported by the steady progress of Yidu Tech's AI healthcare business and the enhancement of its core competitiveness, highlighted by a strategic partnership with Nanshan People's Hospital in Shenzhen to develop an "AI + health management" system [1] Group 2 - Recent business achievements include surpassing 4.5 million insured individuals in the 2026 Beijing Universal Health Insurance project, demonstrating the company's strong capabilities in the healthcare service sector [2] - The launch of the "General Medicine Diagnosis AI Assistant" in collaboration with Chongqing Medical University First Affiliated Hospital has been trialed in over 20 grassroots medical institutions in Chongqing, creating a replicable digital healthcare solution [2] - Industry experts view the company's share repurchase as a positive signal for investors, reflecting confidence in profitability growth and quality improvement, which can help maintain the company's value and enhance investor expectations for future development [2]

Group 1 - The company, Yidu Tech (02158), announced a share buyback on January 28, repurchasing 121,800 shares at approximately HKD 6 per share, totaling around HKD 730,000. This marks the fourth consecutive trading day of buybacks, with a total of approximately 830,000 shares repurchased and nearly HKD 5 million spent, signaling confidence to the market [1] - The company has achieved significant progress in business expansion and product implementation, with the number of participants in the 2026 "Beijing Universal Health Insurance" exceeding 4.5 million. As the main operating platform for this project for five consecutive years, Yidu Tech demonstrates its operational strength and market recognition [1] - Yidu Tech has made breakthroughs in the application of AI in primary healthcare, with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University First Affiliated Hospital being implemented in over 20 grassroots medical institutions in Chongqing since its trial run in May 2025, serving more than 1,000 healthcare professionals [1]

Core Viewpoint - The company, Yidu Tech (02158), is actively engaging in share buybacks to instill market confidence while simultaneously achieving significant progress in business expansion and product implementation [1] Group 1: Share Buyback Activity - On January 28, Yidu Tech announced a share buyback of approximately 121,800 shares at around HKD 6 per share, costing about HKD 730,000 [1] - The company has conducted buybacks for four consecutive trading days, totaling approximately 830,000 shares and nearly HKD 5 million in expenditure [1] Group 2: Business Expansion - The number of participants in the 2026 "Beijing Universal Health Insurance" program, which Yidu Tech operates, has surpassed 4.5 million [1] - Yidu Tech has been the main operating platform for this project for five consecutive years, demonstrating its operational strength and market recognition [1] Group 3: Technological Advancements - Yidu Tech has made breakthroughs in the application of AI in healthcare, specifically with the "General Medicine Diagnosis AI Assistant" developed in collaboration with Chongqing Medical University [1] - Since its trial run in May 2025, the AI assistant has been implemented in over 20 grassroots medical institutions in Chongqing, serving more than 1,000 healthcare professionals [1]